Table Of Content

SUBJECT INDEX TO VOLUME 44 (+)-Huprine Y, 749 (+)-Huprine Z, 749 17B-Estradiol, 584 2,3 DHBA, 2,3 dihydroxybenzoic acid, 787 2,5 DHBA, 2,5 dihydroxybenzoic acid, 787 3,4-methylenedioxymethamphetamine, 439 4-AP, 4-aminopyridine, 686 40 Hz oscillations, 864 5-choice serial reaction time task, 324 5-CT, 1031 5-CT, 5-carboxamidotryptamine, 873 5-HT, : 893 5-HT, 5-hydroxytryptamine, 43] 5-HT, 5-hydroxytryptamine (serotonin), 873 5-HTI1A, 893 5-HTI1A receptor, 562, 873 5-HT7 receptor, 1031 5-HT,, receptor, 206 5-HT;, receptors, 93 5-HT,,, 5-HT3, 1022 5-HT>,, receptor function, 911 5-HT>, receptors, 604 5-HT< receptor, 439 5-HT>< receptor function, 911 5-HT;3,, serotonin type 3A, 43] 5-HT; receptors, 214 5-Hydroxytryptamine, , 431 5-Hydroxytryptamine (5-HT) release, 367 5a-reductase, 49 606, 324 8-Br-cAMP, 8-bromo-cyclic-3’,5’-adenosine monophosphate, 686 8-OH-DPAT, 8-(hydroxy-2-(di-n-propylamino)tetralin, 873 [*°S]GTPYS autoradiography, 93 [*H]glutamate binding, 199 A A-437203, 1047 ABT-418, 1054 AC, adenylyl cyclase, 686 Acetylcholine, 40 ACh, acetylcholine, 765 AChE inhibitor, 749 ACSF, artificial cerebral-spinal fluid, 493 Addiction, 926 Adenosine, 686 Adenosine 3’,5'-cyclic monophosphate, 672 Adenylyl cyclase, 686 Agarose, 817 Aggregation, 403 Aggression, 911 Aging, 381 Akt, 482 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-X1X IX Alpha-2 agonists, 739 Alzheimer’s disease, 749 AM-36, 1-(2-(4-chloropheny])-2-hydroxy )ethyl-4-(3,5-bis(1,1-dimethyl)-4- 787 hydroxyphenyl)methylpiperazine, Aminoguanidine, 253 AMPA, 163, 462, 801 AMPA receptor, 70 AMPA receptor potentiator, 1013 AMPA receptors, 81, 88 Amphetamine, 717 Amygdala, 516, 926, 1068 Analgesia, 264 Analgesic, 413 Animal models, 234 Anion-selective, 43] Anisotropy, 642 Anoxia/reoxygenation, 642 Anticonvulsant, 413 Antidepressant, 562, 616, 801, 893, 1013 Antidepressants, 903 Antinociception, 304 Antipsychotics, 604 Anxiety, 367, 516 Anxiolytic, 562 Apoptosis, 482 Appetite, 264 Approach-avoidance, 473 AR-R17779, 1054 Arc, 893 Arf, 171] ASIC3, 662 Astrocytes, 17] ATP, 132 Attention, 1054 Audiogenic seizures, 275 Autoradiography, 11] AVP 4.0, 541 Axonal transport, 1107 B BAPTA, 1,2-bis(aminophenoxy)-ethane-N,N,N,N’-tetraacetic acid, 493 BDNF, brain-derived neurotrophic factor, 482 Behavioral sensitization, 102 Behaviour, 253, 592, 616 Benzodiazepine receptors, 111 BIC, (—)-bicuculline methochloride, 765 Bicuculline, 157 BK channels, 855 Blood pressure, 757 Body temperature, 1047 Brain, 413 Brain slice, 49 Brain-derived neurotrophic factor (BDNF), 903 BrdU, 5-Bromo-2’-deoxy-uridine, 482 Brefeldin A, 1107 Bungarotoxin, 224 X Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-XIX C C-fos, 264 Ca?*-binding protein, 707 Calcium, 686 Calcium imaging, 41, 214 Calcium mobilization, 14] Calcium pools, 390) CaMKII, Vesicle mobilization, 390) cAMP, 141, 686, 1038 cAMP, cyclic-3’,5'-adenosine monophosphate, 686 cAMP-dependent protein kinase, 686 Cannabinoid, 264 Capsaicin, 958 Capsiate, 958 Caspase, 1068 Cation-selective, 431 Ca**, 132, 541 Ca’ oscillations, 855 Ca’** response, 873 CCh, carbachol, 40 CCK receptor antagonists, 524 Central sensitization, 423 Cerebral blood flow, 653 cFos, 1089 CHA, N°-cyclohexyladenosine, 686 Chick L247T/C189-190SQ7 mutant, 765 Chick L247T@7 mutant, 765 CHO, Chinese hamster ovary, 873 Cholecystokinin, 524 Cholinergic, 224 Cholinesterase inhibitor, 381 Chronic constriction injury, 983 Cingulate cortex, 757 Clonidine, 739 Clozapine, 604 CLT, chelerythrine, 493 Cocaine, 342 Cognition, 324 Cognitive function, 845 Conjugated 17f-estradiol, 584 Consciousness, 864 Cortical neurons, 482 Cortical spreading depression, 949 Corticosterone, 555 COX-2, 374 CP101, 324 CREB, 26 Cultured sympathetic neurons, 1107 Cyclin-dependent kinase 5, 1089 Cytisine, 503 D D2 receptor, 354 D4 agonist, 473 DA, dopamine, 787 DAMGO, [d-Ala’, N-Me-Phe*, Gly°-olJenkephalin, 482 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-XIX XI Delayed match to position, 324 Delayed response task, 38] Dentate gyrus, 374 Depression, 516, 616 Descending modulation, 983 Desensitization, 132, 699 Development, 181 Diazepam, 190 dihydro-B-erythroidine (DHBE), Nicotine, methyllycaconitine (MLA), 367 DMEM, Dulbecco’s modified Eagle’s medium, 482 DMSO, dimethysulfoxide, 43] DOI, 911 DOPAC, 3,4-dihydroxyphenylacetic acid, 787 Dopamine, 190, 354, 449, 633, 717, 926 Dopamine antagonists, 199 Dopamine D2 receptors, 102 Dopamine D4 receptors, 1038 Dopamine microdialysis, 342 Dopamine receptors, 81 Dorsal hippocampus, 367 Dorsal raphe nucleus, 206 Dorsal root ganglion, 132, 141 DPCPX, 8-cyclopentyl-1,3-dipropylxanthine, 686 DRG neuron, 662 DRL, 324 Drug addiction, 102 Drug discrimination, 604 D, receptor, 1047 D, receptor, 1047 D, receptors, 604 D, receptor, 1047 E Ecstasy, 449 Efficacious and partial agonists, 873 EGTA, ethylene glycol-bis((-aminoethyl ether) N,N,N’,N’-tetra acetic acid, 43] Eight-arm radial maze, 533 Electroconvulsive shock, 911 Electroencephalogram, 1068 Electroencephalograph, 234 Electrophysiology, 8 Elevated plus-maze, 439 Ensemble recording, 633 Enteric nervous system, 524 Epibatidine, 1054 Epilepsy, 157, 234, 1068 ERK, extracellular signal-regulated kinase, 482 ET-1, endothelin-1, 787 Ethanol withdrawal, 275 EtOH, ethanol, 493 Excitability, l Excitatory amino acids, 811 Excitotoxicity, 117 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-X1X F F 13640, N-(3-chloro-4-fluorobenzoy!)-4-fluoro-4-[(5-methylpyridin-2-yl)- 873 methylaminomethyl] pipe-ridine, F 14679, N-(3-chloro-4-fluorobenzoy1)-4-fluoro-4-[(5-methyl-6-methylamino 873 pyridin-2-yl)-methylaminomethy]]-piperidine, Fasting, 199 FCS, fetal calf serum, 482 Fear conditioning, 1089 Fiber volley, 26 Fluoxetine, 93, 342 Fluvoxamine, 342 FMRFamide-related neuropeptides, 662 Focal ischemia, 787 Focal stimulation, 1022 Food intake, 199 Foot drumming, 516 Forced swimming test, 616 Fos, 264 Frequency facilitation, 968 Freshly isolated neurons, 493 Frontal cortex, 584 Fusion protein, 873 G G protein-coupled inward rectifier potassium channels, 699 G protein-coupled receptor kinase, 699 G proteins, 93 GABA, 163, 190, 304 GABA release, 1022 GABA, y-aminobutyric acid, 493 GABA, y-aminobutyric acid, 43] GABA, antagonists, 994 GABA, partial agonists, 994 GABA, receptor, , 864 GABA, receptor—ionophore complex, 994 GABA,, type A GABA receptor, 43] GABAg, type C GABA receptor, 43] Galanin, 206 GC cell culture, 672 Gender differences, 624 Gene targeting, 882 General anaesthesia, 864 Glu-Cl, glutamate-gated Cl~ channel, 43] Glutamate, 8, 88, 171, 717 Glutamate release, 282, 390, 686 Glutamate-sensitizing activity, 117 Glutathione peroxidase, 449 Gly, glycine, 493 Golgi, 1107 Golgi cell, 181 GPCR, 773 GPCR mutations, 125 GPCR, G protein-coupled receptor, 482 GPCR, G-protein-coupled receptors (GPCRs), 686 Granule cell, 181 Growth hormone, 672 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-X1X XI GST pull-down, 817 Guanabenz, 739 H Halocytisines, 503 Halogenated ethers, 811 HEK 293 cells, 829, 1003 Hemorrhagic shock, 244 HEPES, N-2-hydroxyethylpiperazine-N-2-etanesulfonicacid, 43] High extracellular potassium, 949 Hippocampal neurons, 707 Hippocampus, 17, 40, 206, 282, 584, 592, 845, 903, 968, 1013, 1068, 1089 Histamine H, receptor, 773 HU210, 633 Human L248To7 mutant, 765 Huperzine A, 749 HVA, 4-hydroxy-3-methoxy-phenylacetic acid, 787 Hyperalgesia, 983 Hyperpolarization-activated cation channel (/,, channel), 968 Hypertension, 757 Hypoglycemia, 199 Hypothalamic—pituitary—adrenal axis, 555 Hypothalamus, 264, 845, 940 Hypothermia, 1031 Hypothyroidism, 111 Hypoxia, 801 I IBMX, 3-isobutyl-1-methylxanthine, 686 ICL, intracellular loop, 873 Immunoprecipitation, 817 Impulsivity, 324 In situ patch-clamp, 49 iNOS inhibitor, 244 InsP3 receptors, 390 Insulin, 855 Interictal-like activity, 157 Interleukin- 1, 801 Intracellular calcium, 282 Intracellular Ca**, 672 Ion channel blocker, 413 Ion channels, 845 Ionic homeostasis, 949 IPSCs, 181 Isoarecolone, 1054 IGiy, glycine current, 493 I... 293 K Ketamine, 729 Knock-out, 190 KO mice, 653 Kv1.1, 829 K,+rp Channels, 855 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIIl-XIX L L-741,626, 1047 L-750667, 1038 L-NAME, 533 L247T, chick L247Ta@7 mutant, 765 L247T-C189S—C190S, chick L247T/C189-190S@7 mutant, 765 L248T, human L248To7 mutant, 765 Lateral fluid-percussive brain injury, 253 Leak channels, | Leptin, 845 LGIC, ligand gated ion channels, 43] Ligand-gated ion channel, 43] Limbic system, 757 Locomotion, 473 Locomotor activity, 717 Locus coeruleus, 88 Long-term depression, 968 Long-term plasticity, 707 Long-term potentiation, 26, 968 LTD, 40, 374 LTP, 17, 40, 374 LY 367385, 8 LY45 1646, 1013 M m-chloropheny|piperazine, 439 MABP, 244 Magnetic resonance imaging, 253 MAPK, 855 MAPK, mitogen-activated protein kinase, 482 MCA, middle cerebral artery, 787 mCPP, 911 MDL100,907, 604 Medial prefrontal cortex, 462 Mediobasal hypothalamus, 354 MEK, mitogen-activated protein kinase and ERK kinase, 482 Membrane estrogen receptor, 584 Memory, 38] Metabotropic glutamate receptor, 157, 699, 983 Metabotropic glutamate receptors, 17, 293, 555, 707, 717 Metabotropic glutamate subtype-5 receptor, 423 Methimazole, 111 mGluR! KO mice, 157 mGluRS, 562 mGluR5 KO mice, 157 Mg?*, 132 Mice, 555 Microdialysis, 206, 354, 533, 592, 787, 949 Mitochondria, 642 Molecular modeling, 773 Monoclonal antibody K1C3, 829 Morphine, 304 Morphine withdrawal, 88 Mossy fiber, 968 Mouse, 1031 MPEP, 8 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-XIX XV MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 482 Muscarinic acetylcholine receptors, 293 Muscarinic receptors, 653 Muscarinic, receptor, 541 Mutagenesis, 699, 773 N N-methyl-d-aspartate, 190 nAChR, nicotinic acetylcholine receptor, 43] Naloxone, 264 541 NC-1900, Neuroblastoma, 214 Neurochemistry, 882 Neurodegeneration, 624 Neurogenesis, lO 13 Neurokinin A, 117 Neurokinin B, 117 1100 Neuroleptics, Neurological functions, 244 Neuronal apoptosis, 253 Neuronal excitability, 845 Neuronal nicotinic receptors, 503 983 Neuropathy, 282 Neuropeptide Y, Neuroprotection, 253, 787, 801 49 Neurosteroid, 994 Neurosteroids, Neurotoxicity, 449, 624, 739 390 NGF, 224, 642, 1054 Nicotine, 234 Nicotinic, 70 Nicotinic acetylcholine receptor, 224 Nicotinic receptors, 624 Nigrostriatal, 949 Nitric oxide, 616, 949 Nitric oxide synthase, 516 NK, receptor, 163, 275, 462, 801 NMDA, 729, 739 NMDA antagonists, 70 NMDA receptor, 81 NMDA receptors, 533 NO, 949 NO donor, 132, 141, 423 Nociception, 38] Non-human primate, 958 Non-pungency, 757 Noradrenaline, 473 Novelty seeking, 324 NR2A knockout mice, 374 NS398, 102, 342, 592, 926, 940 Nucleus accumbens, 949 Nw-nitro-L-arginine methyl ester (L-NAME), O 462 Olanzapine, 958 Olvanil, XVI Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-XIX Open field, 473 Opioid, 264, 482, 573 Opioid receptors, 111 Oxidative stress, 1100 P P2X, 403 P2X receptors, 311 p38 MAPK, 374 Pain, 304, 958 Paired recording, 18] Paired-pulse facilitation, 968 Parathyroid hormone receptor 2, 14] Parkinson’s disease, 624, 642 Patch-clamp, 214, 493, 829 Paw thermal stimulation, 739 PBS, phoshate-buffered saline, 482 PD 128907, 1047 Pelvic nerve, 163 Pentylenetetrazole, 234 Periaqueductal gray, 275 Periaqueductal gray neuron, 573 Peristaltic reflex, 524 pH, 403 Phencyclidine, 462 Philanthotoxin, 70 Phosphatidylinositol 3-kinase, 482 Phosphodiesterase, 686 Phospholipase C, 17] Phospholipase D, 171 Phosphorylation, 26, 493, 686, 699, 829 PI 3-K, phosphatidylinositol 3-kinase, 482 PI 3-kinase, 855 Picrotoxin, 43] PKA, cAMP-dependent protein kinase, 686 PKC phosphorylation site, 873 PKC, protein kinase C, 493, 686, 873 PKC,-TIP, protein kinase C, translocation inhibitor peptide, 493 PKC,-TIP-NC, protein kinase C, translocation inhibitor peptide negative 493 control, PLC, phospholipase C, 873 PMA, phorbol 12-myristate 13-acetate, 873 PMA, phorbol-12-myristate-13-acetate, 493 Prefrontal cortex, 926 Prepulse inhibition, 324, 729 Presynaptic G-protein-coupled receptors, 686 Presynaptic receptors, 311, 882 Progenitor cell, 1013 Programmed cell death, 1068 Prolactin, 940 Protein expression, 1003 Protein kinase A, 573, 829 Protein kinase C, 26, 171, 573, 829 Protein synthesis, 26, 707 Psychosis, 729 PTX, pertussis toxin, 482 Subject Index for Volume 44 / Neuropharmacology 45 (2003) VIII-X1X XVI PTX, picrotoxin, 43] PTZ, pentylenetetrazole, 43] Pudendal nerve, 163 Purinergic, 403 Q Quercetin, 1100 Quinpirole, 102 R RA, retinoic acid, 482 Radioligand binding, 672 Rapid agonist application, 1003 Rat, 244, 324, 423 Reactive oxygen species, 787 Receptor—receptor interaction, 206 Reinforcement, 633 Repeated ischemia, 533 Respiratory control ratio, 642 Resting potential, | Retina, 1038 Reward, 264 Rho, 171 RO20-1724, 4-(3-butoxy-4-methoxyphenyl) methyl-2-imidazolidone, 686 ROS, reactive oxygen species, 787 Rostral ventromedial medulla, 983 Rp-cAMPS, Rp-cyclic-3’,5’-adenosine-monophosphothioate, 686 Ryanodine receptors, 390 S Salicylate hydroxylation, 787 Satiety signal, 845 Saturability, 653 SCH 23390, 1047 Schizophrenia, 604, 729 Scopolamine-induced convulsions, 199 Seizure, 234 Selenium, 449 Sepharose, 817 Septum, 1089 Serotonin, 206, 214, 304, 439, 449, 592, 616 Sevoflurane, 81] Sex differences, 38] Sexual receptivity, 354 SH-SYS5Y cells, 482 Sheep, 354 Signal transduction, 773 Signalling pathways, 845 Single bouton, 1022 SK1, 817 SKF 105111, 49 Small intestine, 524 Social interaction, 439 Sodium channels, 413 Sp4, 1089 Spatial memory, 533, 541